Mitsui & Co., Ltd.
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Mitsui & Co., Ltd.
Astellas’s senior director, head of enterprise insights and digital solutions, digital, analytics and technology tells Scrip how data analytics and deductive hypothesis-oriented simulation are driving improved strategic decision-making across the organization. He also outlined some early generative AI use cases and the promise of digital twins in medicine.
McKinsey & Company's senior partner Vikas Bhadoria, in this first instalment of a wide-ranging two-part interview with Scrip, outlines a number of use cases to define where pharma currently is and the potential value that can be unlocked as industry adopts new technologies such as generative AI, digital twins and the metaverse.
2019 saw Indian companies advance innovation efforts and build and expand their specialty portfolios and biosimilars businesses. But manufacturing compliance issues weighed down several firms while on another front charges against the Singh brothers of Ranbaxy escalated.
The past decade witnessed a bout of pharma 'shock and awe' events in India, some of which still reverberate across the industry. The period also marked the death of doyens of the Indian pharmaceutical sector, including the founders of Dr Reddy’s and Lupin.
- Other Names / Subsidiaries
- Mitsui & Co. (Canada) Ltd.
- Mitsui & Co. (U.S.A.), Inc.
- Mitsui De Mexico, S. De R.L. De C.V.
- Mitsui & Co. Venezuela C.A.
- Mitsui & Co. (Chile) Ltda.
- Mitsui & Co. (Argentina) S.A.
- Mitsui & Co. Europe Plc
- Mitsui & Co. Norway A. S.
- Mitsui & Co. Deutschland Gmbh
- Mitsui & Co. India Pvt. Ltd.
- Mitsui & Co.(Asia Pacific) Pte. Ltd.
- Mitsui & Co NZ Limited
- MITSUI & CO. (AUSTRALIA) LTD.
- MITSUI & CO. (CHINA) LTD.
- Mitsui & Co. (Taiwan) Ltd.
- Mitsui & Co. (Hong Kong) Ltd.
- P T. Mitsui Indonesia
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.